CV Sciences Inc is a pharmaceutical company. The group operates in two segments consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures and markets products based on hemp-based Cannabidiol (CBD). Whereas the specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient.
Quote | CV Sciences Inc. (OTCMKTS:CVSI)
Last: | $0.0515 |
---|---|
Change Percent: | -0.96% |
Open: | $0.0495 |
Close: | $0.052 |
High: | $0.052 |
Low: | $0.0485 |
Volume: | 478,091 |
Last Trade Date Time: | 07/31/2024 03:00:00 am |
News | CV Sciences Inc. (OTCMKTS:CVSI)
2024-05-14 14:10:24 ET CV Sciences, Inc. (CVSI) Q1 2024 Earnings Conference Call May 14, 2024 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participants Presentation Operator ...
2024-05-14 09:09:46 ET More on CV Sciences CV Sciences acquires Elevated Softgels Financial information for CV Sciences Read the full article on Seeking Alpha For further details see: CV Sciences Non-GAAP EPS of $0.00, revenue of $4M
Message Board Posts | CV Sciences Inc. (OTCMKTS:CVSI)
Subject | By | Source | When |
---|---|---|---|
https://www.mdpi.com/1422-0067/24/9/7773 | Thomas@yahoo | investorshub | 05/01/2023 10:42:02 AM |
https://journals.lww.com/clinicalneuropharm/fulltext/9900/medical_cannabis_in_th | Thomas@yahoo | investorshub | 05/01/2023 10:37:36 AM |
https://www.msn.com/en-us/money/companies/battle-over-delta-8-is-heating-up-nati | Dean14 | investorshub | 04/29/2023 1:15:13 PM |
https://link.swansonvitamins.com/view/614df074ee9613022e762f90in90a.9za1/62e9a3e | Thomas@yahoo | investorshub | 04/29/2023 11:38:39 AM |
https://mailchi.mp/42ce7958a786/ushr-advocates-for-2023-farm-bill-priorities-and-fda-regulation-of-c | Thomas@yahoo | investorshub | 04/28/2023 9:59:41 PM |
News, Short Squeeze, Breakout and More Instantly...
CV Sciences, Inc. Reports First Quarter 2024 Financial Results PR Newswire SAN DIEGO , May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex...
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER PR Newswire SAN DIEGO , May 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer we...
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024 PR Newswire SAN DIEGO , May 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company special...